Omeros Correlations

OMER Stock

USD 7.63 0.86 10.13%

The current 90-days correlation between Omeros and Oric Pharmaceuticals is -0.1 (i.e., Good diversification). The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Omeros Correlation With Market

Average diversification

The correlation between Omeros and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

Moving together with Omeros Stock

0.85	ESPR	Esperion Therapeutics	Pair Corr
0.74	BMY	Bristol Myers Squibb	Pair Corr
0.68	XAIR	Beyond Air	Pair Corr
0.77	CAH	Cardinal Health	Pair Corr
0.78	LNSR	LENSAR Inc	Pair Corr
0.75	MMSI	Merit Medical Systems	Pair Corr
0.77	ATEC	Alphatec Holdings	Pair Corr
0.67	CTKB	Cytek Biosciences	Pair Corr

Moving against Omeros Stock

0.84	AMGN	Amgen Inc	Pair Corr
0.75	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.74	AVDL	Avadel Pharmaceuticals	Pair Corr
0.68	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.66	TTOO	T2 Biosystms	Pair Corr
0.63	LLY	Eli Lilly	Pair Corr
0.58	ABBV	AbbVie Inc	Pair Corr
0.53	AQST	Aquestive Therapeutics	Pair Corr
0.52	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.52	SNDL	SNDL Inc	Pair Corr
0.52	AHG	Akso Health Group	Pair Corr
0.49	AKAN	Akanda Corp	Pair Corr
0.82	XTNT	Xtant Medical Holdings	Pair Corr
0.82	GCTK	GlucoTrack	Pair Corr
0.77	MASS	908 Devices	Pair Corr
0.74	TFX	Teleflex Incorporated	Pair Corr
0.54	BIOFILCHEM	Biofil Chemicals Pha	Pair Corr
0.51	TNDM	Tandem Diabetes Care	Pair Corr
0.35	SSY	SunLink Health Systems	Pair Corr

Related Correlations Analysis

	CRNX	ENTA	FOLD	CERE	CNTB	LGND	PASG	ORIC	LYEL	DSGN
CRNX		-0.06	0.09	0.03	-0.52	0.73	0.04	-0.27	-0.41	0.59	CRNX
ENTA	-0.06		0.79	0.4	0.47	-0.55	-0.39	0.12	0.59	-0.41	ENTA
FOLD	0.09	0.79		0.15	0.43	-0.39	-0.13	0.08	0.44	-0.18	FOLD
CERE	0.03	0.4	0.15		0.06	-0.06	-0.06	0.32	0.33	-0.01	CERE
CNTB	-0.52	0.47	0.43	0.06		-0.77	-0.07	0.15	0.51	-0.59	CNTB
LGND	0.73	-0.55	-0.39	-0.06	-0.77		0.29	-0.13	-0.6	0.69	LGND
PASG	0.04	-0.39	-0.13	-0.06	-0.07	0.29		0.25	-0.2	0.36	PASG
ORIC	-0.27	0.12	0.08	0.32	0.15	-0.13	0.25		0.65	0.12	ORIC
LYEL	-0.41	0.59	0.44	0.33	0.51	-0.6	-0.2	0.65		-0.26	LYEL
DSGN	0.59	-0.41	-0.18	-0.01	-0.59	0.69	0.36	0.12	-0.26		DSGN
	CRNX	ENTA	FOLD	CERE	CNTB	LGND	PASG	ORIC	LYEL	DSGN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FOLD	+ 0.79	ENTA
LGND	+ 0.73	CRNX
DSGN	+ 0.69	LGND
LYEL	+ 0.65	ORIC
DSGN	+ 0.59	CRNX
LYEL	+ 0.59	ENTA

High negative correlations

LGND	- 0.77	CNTB
LYEL	- 0.6	LGND
DSGN	- 0.59	CNTB
LGND	- 0.55	ENTA
CNTB	- 0.52	CRNX
DSGN	- 0.41	ENTA

Risk-Adjusted Indicators

There is a big difference between Omeros Stock performing well and Omeros Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omeros' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	1.81	0.02	0.00	0.11	2.83	(1.63)	4.04	(3.82)	16.75
ENTA	2.75	(1.05)	0.00	(1.39)	0.00	0.00	3.68	(5.92)	30.73
FOLD	1.63	(0.31)	0.00	(0.46)	0.00	0.00	3.16	(3.96)	18.26
CERE	0.77	0.10	(0.01)	(0.27)	0.94	(1.02)	1.91	(1.59)	6.40
CNTB	3.99	(0.04)	(0.01)	0.03	4.82	(4.42)	8.47	(9.01)	23.62
LGND	2.04	0.10	0.05	0.16	2.94	(1.92)	4.11	(5.43)	17.92
PASG	6.36	0.21	0.05	0.15	6.70	(8.01)	12.07	(11.86)	84.39
ORIC	2.89	(0.24)	0.00	(0.01)	0.00	0.00	5.64	(5.60)	23.18
LYEL	5.17	(0.94)	0.00	(0.14)	0.00	0.00	13.39	(10.68)	36.92
DSGN	3.99	(0.18)	0.00	0.03	5.95	(3.84)	7.89	(8.80)	33.11

Omeros Corporate Management

Peter JD	General VP	Profile
Michael Jacobsen	Principal Financial Officer, Chief Accounting Officer, VP of Fin. and Treasurer	Profile
Nadia Dac	VP Officer	Profile
Debra MT	Chief Officer	Profile
Andreas MD	Chief Officer	Profile
Gregory MD	Chairman, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC